2021
DOI: 10.1007/s00125-021-05386-7
|View full text |Cite
|
Sign up to set email alerts
|

Two decades since the fetal insulin hypothesis: what have we learned from genetics?

Abstract: In 1998 the fetal insulin hypothesis proposed that lower birthweight and adult-onset type 2 diabetes are two phenotypes of the same genotype. Since then, advances in research investigating the role of genetics affecting insulin secretion and action have furthered knowledge of fetal insulin-mediated growth and the biology of type 2 diabetes. In this review, we discuss the historical research context from which the fetal insulin hypothesis originated and consider the position of the hypothesis in light of recent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
35
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(37 citation statements)
references
References 81 publications
2
35
0
Order By: Relevance
“…In 1998, Hattersley and Tooke put forth the ‘fetal insulin’ hypothesis as an alternative explanation for the association between low birth weight and risk of T2D. This hypothesis proposes that both phenotypes are the result of a genetic predisposition for reduced insulin secretion and action leading to decreased growth in fetal life and a decreased capacity to secrete and respond to insulin and, therefore, higher T2D risk [ 7 , 8 ]. Support for the ‘fetal insulin’ hypothesis emerged from genome-wide association studies showing that a number of T2D risk loci are associated with lower birthweight.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 1998, Hattersley and Tooke put forth the ‘fetal insulin’ hypothesis as an alternative explanation for the association between low birth weight and risk of T2D. This hypothesis proposes that both phenotypes are the result of a genetic predisposition for reduced insulin secretion and action leading to decreased growth in fetal life and a decreased capacity to secrete and respond to insulin and, therefore, higher T2D risk [ 7 , 8 ]. Support for the ‘fetal insulin’ hypothesis emerged from genome-wide association studies showing that a number of T2D risk loci are associated with lower birthweight.…”
Section: Introductionmentioning
confidence: 99%
“…Support for the ‘fetal insulin’ hypothesis emerged from genome-wide association studies showing that a number of T2D risk loci are associated with lower birthweight. Furthermore, the strongest associations are at loci that primarily affect beta-cell function (reviewed in [ 8 ]). However, it has since been argued that genetic susceptibility does not solely account for the relationship between low birth weight and T2D; in a study of monozygotic twins discordant for T2D, the diabetic twin had a lower birth weight compared to their genetically identical non-diabetic co-twin [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Fetal insulin secretion is known to be a major determinant of birthweight, particularly in humans [ 4 , 5 ]. Our analysis of individuals with complete absence of fetal insulin secretion, due to mutations in the insulin gene or pancreatic agenesis, have shown they are half the normal birthweight [ 5 ].…”
mentioning
confidence: 99%
“…Fetal insulin secretion is known to be a major determinant of birthweight, particularly in humans [ 4 , 5 ]. Our analysis of individuals with complete absence of fetal insulin secretion, due to mutations in the insulin gene or pancreatic agenesis, have shown they are half the normal birthweight [ 5 ]. Additionally, in individuals with HNF4A mutations, macrosomia has been reported as always occurring in those with neonatal hyperinsulinaemic hypoglycaemia [ 2 ].…”
mentioning
confidence: 99%
See 1 more Smart Citation